본문 바로가기
HOME> 저널/프로시딩 > 저널/프로시딩 검색상세

저널/프로시딩 상세정보

권호별목차 / 소장처보기

H : 소장처정보

T : 목차정보

Journal of digestive diseases 9건

  1. [해외논문]   Issue Information   SCIE


    Journal of digestive diseases v.19 no.6 ,pp. 321 - 321 , 2018 , 1751-2972 ,

    초록

    원문보기

    원문보기
    무료다운로드 유료다운로드

    회원님의 원문열람 권한에 따라 열람이 불가능 할 수 있으며 권한이 없는 경우 해당 사이트의 정책에 따라 회원가입 및 유료구매가 필요할 수 있습니다.이동하는 사이트에서의 모든 정보이용은 NDSL과 무관합니다.

    NDSL에서는 해당 원문을 복사서비스하고 있습니다. 아래의 원문복사신청 또는 장바구니담기를 통하여 원문복사서비스 이용이 가능합니다.

    이미지

    Fig. 1 이미지
  2. [해외논문]   Role of fecal microbiota transplantation in inflammatory bowel disease   SCIE

    D'Odorico, Irene (University of Trieste, Trieste, Italy) , Di Bella, Stefano (Infectious Diseases Division, University Hospital of Trieste, Trieste, Italy) , Monticelli, Jacopo (Infectious Diseases Division, University Hospital of Trieste, Trieste, Italy) , Giacobbe, Daniele R (Infectious Diseases Unit, OspedalePoliclinico San Martino‐IRCCS per l'Oncologia and University of Genoa, Genoa, Italy) , Boldock, Emma (Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK) , Luzzati, Roberto (Infectious Diseases Division, University Hospital of Trieste, Trieste, Italy)
    Journal of digestive diseases v.19 no.6 ,pp. 322 - 334 , 2018 , 1751-2972 ,

    초록

    There is increasing evidence of the key role played by altered intestinal microbiota in the pathogenesis of inflammatory bowel disease (IBD). Management strategies involving immune modulation are effective and widely used, but treatment failures and side effects occur. Fecal microbiota transplantation (FMT) provides a novel, perhaps complementary, strategy to restore the normal gut microbiota in patients with IBD. This review summarizes the available efficacy and safety data on the use of FMT in patients with IBD. Several aspects remain to be clarified about the clinical predictors of the response to FMT, its most appropriate route of administration, and the most appropriate quantity and quality of microbiota to be transplanted. Further studies focusing on long‐term outcomes and safety are also warranted.

    원문보기

    원문보기
    무료다운로드 유료다운로드

    회원님의 원문열람 권한에 따라 열람이 불가능 할 수 있으며 권한이 없는 경우 해당 사이트의 정책에 따라 회원가입 및 유료구매가 필요할 수 있습니다.이동하는 사이트에서의 모든 정보이용은 NDSL과 무관합니다.

    NDSL에서는 해당 원문을 복사서비스하고 있습니다. 아래의 원문복사신청 또는 장바구니담기를 통하여 원문복사서비스 이용이 가능합니다.

    이미지

    Fig. 1 이미지
  3. [해외논문]   Ringer's lactate versus normal saline in acute pancreatitis: A systematic review and meta‐analysis   SCIE

    Iqbal, Umair (Department of Internal Medicine, Bassett Medical Center, Cooperstown, New York, USA) , Anwar, Hafsa (Internal Medicine, Jinnah Sindh Medical University, Karachi, Sindh, Pakistan) , Scribani, Melissa (Department of Statistics, Bassett Medical Center, Cooperstown, New York, USA)
    Journal of digestive diseases v.19 no.6 ,pp. 335 - 341 , 2018 , 1751-2972 ,

    초록

    OBJECTIVE Aggressive i.v. hydration with crystalloids is the first step in managing acute pancreatitis (AP) and is associated with improved survival. Guidelines about the choice of crystalloids to use are unclear. This systematic review and meta‐analysis was aimed to discern whether the choice of fluids in managing pancreatitis was associated with patients' outcomes. METHODS A comprehensive literature review was conducted by searching the Embase, MEDLINE, PubMed and Google Scholar databases to December 2017 to identify all studies that compared normal saline (NS) with Ringer's lactate (RL) for managing AP. The characteristics of the participants, outcome measurements (including mortality, the development of systemic inflammatory response syndrome [SIRS] on admission and at 24 h, and pancreatic necrosis) were analyzed. RESULTS Five studies (three randomized controlled trials and two retrospective cohort studies) with 428 patients were included in this analysis. Mortality trended lower in the RL group but this was not statistically significant (pooled odds ratio [OR] 0.61, 95% CI 0.28–1.29, P = 0.20). Patients in the RL group had significantly decreased odds of developing SIRS at 24 h (pooled OR 0.38, 95% CI 0.15–0.98, P = 0.05). CONCLUSIONS RL has anti‐inflammatory effects and is associated with decreased odds of persistent SIRS at 24 h, which is a marker of severe disease in AP patients. Although mortality trended lower in the RL group this did not achieve statistical significance and hence larger randomized controlled trials are needed to evaluate this association.

    원문보기

    원문보기
    무료다운로드 유료다운로드

    회원님의 원문열람 권한에 따라 열람이 불가능 할 수 있으며 권한이 없는 경우 해당 사이트의 정책에 따라 회원가입 및 유료구매가 필요할 수 있습니다.이동하는 사이트에서의 모든 정보이용은 NDSL과 무관합니다.

    NDSL에서는 해당 원문을 복사서비스하고 있습니다. 아래의 원문복사신청 또는 장바구니담기를 통하여 원문복사서비스 이용이 가능합니다.

    이미지

    Fig. 1 이미지
  4. [해외논문]   Dyspepsia in non‐steroidal anti‐inflammatory drug users and the effect of preventive measures   SCIE

    Lee, Hooi Leng (Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia) , Chua, Siew Siang (Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia) , Mahadeva, Sanjiv (Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia)
    Journal of digestive diseases v.19 no.6 ,pp. 342 - 349 , 2018 , 1751-2972 ,

    초록

    OBJECTIVE To evaluate regular non‐steroidal anti‐inflammatory drug (NSAID) users for dyspepsia, as well as to assess the effect of preventive measures, and the reasons for non‐adherence to gastroprotective agents (GPA) from a real‐world perspective. METHODS A prospective longitudinal study was conducted among outpatients with regular NSAID usage. The presence of dyspepsia was assessed by locally validated versions of the Leeds dyspepsia questionnaire (LDQ), GPA and the participants' adherence to the drugs were assessed at recruitment and 2 weeks later. GPA was defined as the use of antisecretory medications or cyclooxygenase‐2 inhibitors. RESULTS Initially, 409 participants (mean age 52.3 ± 14.6 years, 60.6% females, 48.4% treated for musculoskeletal pain) were recruited. At recruitment, 50.9% of the participants had at least one upper gastrointestinal symptom. Complete data for follow‐up analysis were collected from 158 participants who were naive NSAID users, had no prior gastrointestinal medication and who could be contacted. At 2‐week follow‐up there was no significant difference in the LDQ score change between NSAID users treated with GPA and those did not. However, there was a greater reduction in abdominal pain/discomfort (8.8% vs 5.0%, P vs 4.0%, P CONCLUSIONS The use of GPA in patients on regular NSAIDs does not improve their overall dyspepsia, but it reduces abdominal pain and burping. Poor adherence to GPA may be a contributing factor.

    원문보기

    원문보기
    무료다운로드 유료다운로드

    회원님의 원문열람 권한에 따라 열람이 불가능 할 수 있으며 권한이 없는 경우 해당 사이트의 정책에 따라 회원가입 및 유료구매가 필요할 수 있습니다.이동하는 사이트에서의 모든 정보이용은 NDSL과 무관합니다.

    NDSL에서는 해당 원문을 복사서비스하고 있습니다. 아래의 원문복사신청 또는 장바구니담기를 통하여 원문복사서비스 이용이 가능합니다.

    이미지

    Fig. 1 이미지
  5. [해외논문]   Heat shock protein family A member 6 combined with clinical characteristics for the differential diagnosis of intestinal BehCet's disease   SCIE

    Feng, Rui (Department of Gastroenterology, First Affiliated Hospital, Sun Yat‐sen University, Guangzhou, Guangdong Province, China) , Chao, Kang (Department of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat‐sen University, Guangzhou, Guangdong Province, China) , Chen, Shu Ling (Department of Ultrasonography, First Affiliated Hospital, Sun Yat‐sen University, Guangzhou, Guangdong Province, China) , Sun, Can Hui (Department of Radiology, First Affiliated Hospital, Sun Yat‐sen University, Guangzhou, Guangdong Province, China) , Qiu, Yun (Department of Gastroenterology, First Affiliated Hospital, Sun Yat‐sen University, Guangzhou, Guangdong Province, China) , Chen, Bai Li (Department of Gastroenterology, First Affiliated Hospital, Sun Yat‐sen University, Guangzhou, Guangdong Province, China) , Mao, Ren (De) , He, Yao , Cao, Qing Hua , Xue, Ling , Zeng, Zhi Rong , Zhang, Sheng Hong , Chen, Min Hu
    Journal of digestive diseases v.19 no.6 ,pp. 350 - 358 , 2018 , 1751-2972 ,

    초록

    OBJECTIVE To investigate the role of heat shock protein family A member 6 (HSPA6) expression alone and in combination with clinical characteristics in distinguishing intestinal BehCet’s disease (BD) from Crohn’s disease (CD) with ileocolonic involvement. METHODS Patients diagnosed with either intestinal BD or CD were enrolled. Their clinical characteristics, disease activity, laboratory test results including hypersensitive C‐reactive protein (hsCRP) and erythrocyte sedimentation rate (ESR), endoscopic, pathological and radiological features were retrospectively analyzed. Enzyme‐linked immunosorbent assay was applied to measure serum HSPA6 levels. RESULTS Among intestinal BD patients, abdominal pain and diarrhea were the leading gastrointestinal symptoms. Submucosal lymphocyte infiltration was the most common pathological finding. Computed tomography enterography features involved number of segments of less than 4 and bowel wall thickening. Independent factors were round/ellipsoid intestinal ulcer ( P P = 0.050), elevated ulcer margin ( P = 0.019), absence of aphthous ulcer ( P = 0.005), bowel wall thickening >13 mm ( P 3.725 ng/mL ( P = 0.008) for the differential diagnosis between intestinal BD and CD. Serum HSPA6 expression was significantly elevated in intestinal BD (0.72 ± 0.39 ng/mL) compared with CD (0.50 ± 0.24 ng/mL, P = 0.000) and healthy controls (0.38 ± 0.37 ng/mL, P = 0.000). CONCLUSION HSPA6 in combination with clinical, radiological and pathological characteristics is useful in distinguishing intestinal BD from CD with ileocolonic involvement.

    원문보기

    원문보기
    무료다운로드 유료다운로드

    회원님의 원문열람 권한에 따라 열람이 불가능 할 수 있으며 권한이 없는 경우 해당 사이트의 정책에 따라 회원가입 및 유료구매가 필요할 수 있습니다.이동하는 사이트에서의 모든 정보이용은 NDSL과 무관합니다.

    NDSL에서는 해당 원문을 복사서비스하고 있습니다. 아래의 원문복사신청 또는 장바구니담기를 통하여 원문복사서비스 이용이 가능합니다.

    이미지

    Fig. 1 이미지
  6. [해외논문]   Split‐dose 4‐L polyethylene glycol regimen for patients with previous colorectal surgery in bowel preparation before colonoscopy: A randomized, controlled, single‐blind study   SCIE

    Liu, Zhu (Department of Gastroenterology, Laboratory of Translational Gastroenterology, Shandong University Qilu Hospital, Jinan, Shandong Province, China) , Li, Yue Yue (Department of Gastroenterology, Laboratory of Translational Gastroenterology, Shandong University Qilu Hospital, Jinan, Shandong Province, China) , Luo, Xue Ting (Department of Gastroenterology, Laboratory of Translational Gastroenterology, Shandong University Qilu Hospital, Jinan, Shandong Province, China) , Guo, Chuan Guo (Department of Gastroenterology, Laboratory of Translational Gastroenterology, Shandong University Qilu Hospital, Jinan, Shandong Province, China) , Zhang, Ming Ming (Department of Gastroenterology, Laboratory of Translational Gastroenterology, Shandong University Qilu Hospital, Jinan, Shandong Province, China) , Li, Zhen (Department of Gastroenterology, Laboratory of Translational Gastroenterolog) , Li, Li Xiang , Zhang, Yan , Li, Yan Qing
    Journal of digestive diseases v.19 no.6 ,pp. 359 - 368 , 2018 , 1751-2972 ,

    초록

    OBJECTIVE We aimed to investigate the efficacy of a split‐dose 4‐L polyethylene glycol (PEG) regimen for the quality of bowel preparation in Asian patients with previous colorectal surgery for colorectal cancer (CRC). METHODS This was a prospective, single‐center, randomized controlled, endoscopist‐blinded study. Patients with previous colorectal surgery for CRC were randomly allocated to a routine, morning‐only 2‐L PEG (2‐MO) group or a split‐dose 4‐L PEG (4‐SD) group. The primary outcome was a successful bowel preparation rate. Secondary outcomes were polyp detection rate (PDR), adenoma detection rate (ADR), patient compliance, satisfaction, tolerance, willingness to repeat the preparation and difficulty of the bowel preparation process. RESULTS In total, 187 patients were included (93 in the 2‐MO group, 94 in the 4‐SD group) in this study. The rate of successful bowel preparation in the 4‐SD group was higher than in the 2‐MO group (89.4% vs 66.7%, P vs 82.2%, P = 0.021). No significant differences were detected in PDR, ADR, patient compliance, tolerance, willingness to repeat the preparation or difficulty of the bowel preparation process. CONCLUSIONS The 4‐SD PEG regimen was superior to a routine, morning‐only 2‐L PEG preparation for bowel preparation in an Asian population with previous colorectal surgery.

    원문보기

    원문보기
    무료다운로드 유료다운로드

    회원님의 원문열람 권한에 따라 열람이 불가능 할 수 있으며 권한이 없는 경우 해당 사이트의 정책에 따라 회원가입 및 유료구매가 필요할 수 있습니다.이동하는 사이트에서의 모든 정보이용은 NDSL과 무관합니다.

    NDSL에서는 해당 원문을 복사서비스하고 있습니다. 아래의 원문복사신청 또는 장바구니담기를 통하여 원문복사서비스 이용이 가능합니다.

    이미지

    Fig. 1 이미지
  7. [해외논문]   Prevention of post‐sphincterotomy bleeding by proton pump inhibitor: A randomized controlled trial   SCIE

    Leung, Wai K (Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China) , But, David YK (Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China) , Wong, Siu‐ (Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China) , Yin (Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China) , Tong, Teresa SM (Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China) , Liu, Kevin SH (Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China) , Cheung, Ka‐ (Department of Surgery, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China) , Shing (Department of Surgery, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR,) , Tsang, Simon HY , Chok, Kenneth SH , Poon, Ronnie TP , Hung, Ivan FN
    Journal of digestive diseases v.19 no.6 ,pp. 369 - 376 , 2018 , 1751-2972 ,

    초록

    OBJECTIVE Post‐endoscopic sphincterotomy (EST) bleeding is one of the most frequent complications of endoscopic retrograde cholangiopancreatography (ERCP). Although the use of proton pump inhibitors (PPIs) reduces the risk of peptic ulcer bleeding, their role in preventing EST bleeding has not been evaluated. This study aimed to assess the use of pre‐emptive PPIs in patients undergoing EST. METHODS This was an investigator‐initiated, open‐label, randomized study. Consecutive patients scheduled to undergo ERCP and EST were enrolled after excluding those who had previous EST or used acid‐suppression agents. Eligible patients were randomized to receive either PPI or standard care. The PPI group received intravenous esomeprazole 4 h before the EST and then every 12 h for 1 day, followed by high‐dose oral esomeprazole for 10 days. All patients were followed up for 30 days. The primary outcome was the proportion of patients with combined immediate and delayed overt post‐EST bleeding. RESULTS Altogether 125 patients (60 in the PPI arm and 65 in the standard care arm) who had undergone EST were analyzed. Immediate bleeding was noted in nine (15.0%) patients in the PPI group and four (6.2%) in the standard care group ( P = 0.14). Overt delayed post‐EST bleeding was seen in two (3.3%) and five (7.7%) patients in PPI and standard care arms, respectively ( P = 0.44). There were no significant differences in other outcomes, including a decrease in hemoglobin of >20 g/L, the need for blood transfusion, length of hospital stay and 30‐day mortality. CONCLUSION Pre‐emptive PPI did not reduce the risk of post‐EST bleeding.

    원문보기

    원문보기
    무료다운로드 유료다운로드

    회원님의 원문열람 권한에 따라 열람이 불가능 할 수 있으며 권한이 없는 경우 해당 사이트의 정책에 따라 회원가입 및 유료구매가 필요할 수 있습니다.이동하는 사이트에서의 모든 정보이용은 NDSL과 무관합니다.

    NDSL에서는 해당 원문을 복사서비스하고 있습니다. 아래의 원문복사신청 또는 장바구니담기를 통하여 원문복사서비스 이용이 가능합니다.

    이미지

    Fig. 1 이미지
  8. [해외논문]   Caution with iceberg model for colonoscopy in mind! A large easily missed sessile serrated polyp surrounding seemingly diminutive protruded polyp: A case report   SCIE

    Zhang, Qing Wei (Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Renji Hospital, School of Medicine, Shanghai Jiao Tong University) , Teng, La Mei (Shanghai Institute of Digestive Disease, Shanghai, China) , Tang, Chen Yue (Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Renji Hospital, School of Medicine, Shanghai Jiao Tong University) , Yan, Xia Lin (Shanghai Institute of Digestive Disease, Shanghai, China) , Ge, Zhi Zheng (Department of Gastroenterology, Shanghai Jiao Tong University School of Medicine, Shanghai, China) , Li, Xiao Bo (Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China)
    Journal of digestive diseases v.19 no.6 ,pp. 377 - 380 , 2018 , 1751-2972 ,

    초록

    OBJECTIVE Post‐endoscopic sphincterotomy (EST) bleeding is one of the most frequent complications of endoscopic retrograde cholangiopancreatography (ERCP). Although the use of proton pump inhibitors (PPIs) reduces the risk of peptic ulcer bleeding, their role in preventing EST bleeding has not been evaluated. This study aimed to assess the use of pre‐emptive PPIs in patients undergoing EST. METHODS This was an investigator‐initiated, open‐label, randomized study. Consecutive patients scheduled to undergo ERCP and EST were enrolled after excluding those who had previous EST or used acid‐suppression agents. Eligible patients were randomized to receive either PPI or standard care. The PPI group received intravenous esomeprazole 4 h before the EST and then every 12 h for 1 day, followed by high‐dose oral esomeprazole for 10 days. All patients were followed up for 30 days. The primary outcome was the proportion of patients with combined immediate and delayed overt post‐EST bleeding. RESULTS Altogether 125 patients (60 in the PPI arm and 65 in the standard care arm) who had undergone EST were analyzed. Immediate bleeding was noted in nine (15.0%) patients in the PPI group and four (6.2%) in the standard care group ( P = 0.14). Overt delayed post‐EST bleeding was seen in two (3.3%) and five (7.7%) patients in PPI and standard care arms, respectively ( P = 0.44). There were no significant differences in other outcomes, including a decrease in hemoglobin of >20 g/L, the need for blood transfusion, length of hospital stay and 30‐day mortality. CONCLUSION Pre‐emptive PPI did not reduce the risk of post‐EST bleeding.

    원문보기

    원문보기
    무료다운로드 유료다운로드

    회원님의 원문열람 권한에 따라 열람이 불가능 할 수 있으며 권한이 없는 경우 해당 사이트의 정책에 따라 회원가입 및 유료구매가 필요할 수 있습니다.이동하는 사이트에서의 모든 정보이용은 NDSL과 무관합니다.

    NDSL에서는 해당 원문을 복사서비스하고 있습니다. 아래의 원문복사신청 또는 장바구니담기를 통하여 원문복사서비스 이용이 가능합니다.

    이미지

    Fig. 1 이미지
  9. [해외논문]   Issue Information ‐ PI   SCIE


    Journal of digestive diseases v.19 no.6 ,pp. 384 - 384 , 2018 , 1751-2972 ,

    초록

    OBJECTIVE Post‐endoscopic sphincterotomy (EST) bleeding is one of the most frequent complications of endoscopic retrograde cholangiopancreatography (ERCP). Although the use of proton pump inhibitors (PPIs) reduces the risk of peptic ulcer bleeding, their role in preventing EST bleeding has not been evaluated. This study aimed to assess the use of pre‐emptive PPIs in patients undergoing EST. METHODS This was an investigator‐initiated, open‐label, randomized study. Consecutive patients scheduled to undergo ERCP and EST were enrolled after excluding those who had previous EST or used acid‐suppression agents. Eligible patients were randomized to receive either PPI or standard care. The PPI group received intravenous esomeprazole 4 h before the EST and then every 12 h for 1 day, followed by high‐dose oral esomeprazole for 10 days. All patients were followed up for 30 days. The primary outcome was the proportion of patients with combined immediate and delayed overt post‐EST bleeding. RESULTS Altogether 125 patients (60 in the PPI arm and 65 in the standard care arm) who had undergone EST were analyzed. Immediate bleeding was noted in nine (15.0%) patients in the PPI group and four (6.2%) in the standard care group ( P = 0.14). Overt delayed post‐EST bleeding was seen in two (3.3%) and five (7.7%) patients in PPI and standard care arms, respectively ( P = 0.44). There were no significant differences in other outcomes, including a decrease in hemoglobin of >20 g/L, the need for blood transfusion, length of hospital stay and 30‐day mortality. CONCLUSION Pre‐emptive PPI did not reduce the risk of post‐EST bleeding.

    원문보기

    원문보기
    무료다운로드 유료다운로드

    회원님의 원문열람 권한에 따라 열람이 불가능 할 수 있으며 권한이 없는 경우 해당 사이트의 정책에 따라 회원가입 및 유료구매가 필요할 수 있습니다.이동하는 사이트에서의 모든 정보이용은 NDSL과 무관합니다.

    NDSL에서는 해당 원문을 복사서비스하고 있습니다. 아래의 원문복사신청 또는 장바구니담기를 통하여 원문복사서비스 이용이 가능합니다.

    이미지

    Fig. 1 이미지

논문관련 이미지